PE105799A1 - Suspension farmaceutica que comprende hemihidrato de nevirapina - Google Patents
Suspension farmaceutica que comprende hemihidrato de nevirapinaInfo
- Publication number
- PE105799A1 PE105799A1 PE1998000718A PE00071898A PE105799A1 PE 105799 A1 PE105799 A1 PE 105799A1 PE 1998000718 A PE1998000718 A PE 1998000718A PE 00071898 A PE00071898 A PE 00071898A PE 105799 A1 PE105799 A1 PE 105799A1
- Authority
- PE
- Peru
- Prior art keywords
- nevirapine
- hemihydrate
- nevirapine hemihydrate
- precipitate
- csp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE UNA SUSPENSION ACUOSA DE HEMIHIDRATO DE NEVIRAPINA QUE SE FORMA AL TRATAR UNA SUSPENSION ACUOSA DE NEVIRAPINA ANHIDRO CON UN ACIDO FUERTE, FORMANDO LA SAL DE ADICION DEL ACIDO, LA CUAL SE TRATA CON UNA BASE FUERTE; FORMANDO LA BASE LIBRE COMO PRECIPITADO EN FORMA DE HEMIHIDRATO, EL PRECIPITADO SE SEPARA POR FILTRACION, SE LAVA CON AGUA, SE SECA HASTA QUE EL CONTENIDO DE AGUA SEA ENTRE 3,1% Y 3,9% EN PESO. EL TAMANO DE LAS PARTICULAS DEL HEMIHIDRATO DE NEVIRAPINA DEBE SER ENTRE 1�-150�. UNA FORMULACION DE LA SUSPENSION CONTIENE DE 0,1 g/100ml - 50 g/100 ml DE HEMIHIDRATO DE NEVIRAPINA; DE 0,17 g/100ml - 0,22 g/100ml DE CARBOMERO 934P, NF; DE 0,01 g/100ml - 0,2 g/100ml POLISORBATO 80 NF; DE 5 g/100ml - 30 g/100ml DE SOLUCION DE SORBITOL, USP; DE 5g/100ml - 30 g/100ml DE SACAROSA NF; 0,15 g/100ml - 0,2 g/100ml METILPARABENO, NF; DE 0,02g/100ml - 0,24g/100ml DE PROPILPARABENO, NF; NaOH CSP pH DE 5,5-6,0; AGUA PURIFICADA CSP 100 ml. LA NEVIRAPINA ES UTIL PARA EL TRATAMIENTO DE INFECCION CON VIH-1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5680397P | 1997-08-25 | 1997-08-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE105799A1 true PE105799A1 (es) | 1999-11-16 |
Family
ID=22006658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1998000718A PE105799A1 (es) | 1997-08-25 | 1998-08-11 | Suspension farmaceutica que comprende hemihidrato de nevirapina |
Country Status (38)
Country | Link |
---|---|
US (2) | US6172059B1 (es) |
EP (1) | EP1019058B1 (es) |
JP (1) | JP3472261B2 (es) |
KR (1) | KR100426516B1 (es) |
CN (1) | CN1197578C (es) |
AR (2) | AR016869A1 (es) |
AT (1) | ATE326971T1 (es) |
AU (1) | AU742761B2 (es) |
BG (1) | BG64337B1 (es) |
BR (1) | BR9811994B1 (es) |
CA (1) | CA2301646C (es) |
CL (1) | CL2008003111A1 (es) |
CO (1) | CO4970742A1 (es) |
CY (1) | CY1105228T1 (es) |
CZ (1) | CZ290667B6 (es) |
DE (1) | DE69834655T2 (es) |
DK (1) | DK1019058T3 (es) |
EG (1) | EG24075A (es) |
ES (1) | ES2265666T3 (es) |
HK (1) | HK1027975A1 (es) |
HR (1) | HRP980461B1 (es) |
HU (1) | HU226063B1 (es) |
ID (1) | ID21650A (es) |
IL (1) | IL134185A (es) |
MY (1) | MY122272A (es) |
NO (1) | NO326226B1 (es) |
NZ (1) | NZ503414A (es) |
PE (1) | PE105799A1 (es) |
PL (1) | PL192361B1 (es) |
PT (1) | PT1019058E (es) |
RS (1) | RS49808B (es) |
RU (1) | RU2196584C2 (es) |
SA (1) | SA98190680B1 (es) |
TR (1) | TR200000490T2 (es) |
TW (1) | TW450812B (es) |
UA (1) | UA44370C2 (es) |
WO (1) | WO1999009990A1 (es) |
ZA (1) | ZA987623B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002092095A1 (en) * | 2001-05-11 | 2002-11-21 | Boehringer Ingelheim International Gmbh | Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine |
EP1504040A1 (en) * | 2002-04-23 | 2005-02-09 | Boehringer Ingelheim Pharmaceuticals Inc. | Method for reduction of residual organic solvent in carbomer |
KR20080053317A (ko) * | 2005-08-31 | 2008-06-12 | 씨아이피엘에이 엘티디. | 라미부딘, 스타부딘 및 네비라핀을 포함하는 약학적 조합물 |
US20110082161A1 (en) * | 2008-06-30 | 2011-04-07 | Lieven Elvire Colette Baert | Powders for reconstitution |
BR112012011095A2 (pt) * | 2009-11-10 | 2015-10-06 | Univ Northwest | método para aumentar a solubilidade de uma composição inibidora de transcriptase |
DE112010004862T5 (de) * | 2009-12-17 | 2012-12-06 | North West University | Polymorphe Form von Nevirapin und deren Herstellung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366972A (en) | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
CA2030056C (en) * | 1989-11-17 | 1995-10-17 | Karl D. Hargrave | 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection |
US5571912A (en) * | 1990-10-19 | 1996-11-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines |
DE4403311C1 (de) * | 1994-02-03 | 1995-04-20 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on) |
-
1998
- 1998-08-11 UA UA2000031668A patent/UA44370C2/uk unknown
- 1998-08-11 AT AT98939312T patent/ATE326971T1/de active
- 1998-08-11 AU AU87771/98A patent/AU742761B2/en not_active Ceased
- 1998-08-11 WO PCT/US1998/016581 patent/WO1999009990A1/en active IP Right Grant
- 1998-08-11 US US09/131,829 patent/US6172059B1/en not_active Expired - Lifetime
- 1998-08-11 BR BRPI9811994-0B1A patent/BR9811994B1/pt not_active IP Right Cessation
- 1998-08-11 KR KR10-2000-7001889A patent/KR100426516B1/ko not_active IP Right Cessation
- 1998-08-11 CA CA002301646A patent/CA2301646C/en not_active Expired - Fee Related
- 1998-08-11 TR TR2000/00490T patent/TR200000490T2/xx unknown
- 1998-08-11 RU RU2000107825/14A patent/RU2196584C2/ru not_active IP Right Cessation
- 1998-08-11 DK DK98939312T patent/DK1019058T3/da active
- 1998-08-11 NZ NZ503414A patent/NZ503414A/xx not_active IP Right Cessation
- 1998-08-11 HU HU0003093A patent/HU226063B1/hu not_active IP Right Cessation
- 1998-08-11 PL PL338828A patent/PL192361B1/pl unknown
- 1998-08-11 EP EP98939312A patent/EP1019058B1/en not_active Expired - Lifetime
- 1998-08-11 JP JP2000507380A patent/JP3472261B2/ja not_active Expired - Fee Related
- 1998-08-11 CN CNB988084899A patent/CN1197578C/zh not_active Expired - Fee Related
- 1998-08-11 ES ES98939312T patent/ES2265666T3/es not_active Expired - Lifetime
- 1998-08-11 DE DE69834655T patent/DE69834655T2/de not_active Expired - Lifetime
- 1998-08-11 PT PT98939312T patent/PT1019058E/pt unknown
- 1998-08-11 CZ CZ2000694A patent/CZ290667B6/cs not_active IP Right Cessation
- 1998-08-11 IL IL13418598A patent/IL134185A/xx not_active IP Right Cessation
- 1998-08-11 RS YUP-98/00A patent/RS49808B/sr unknown
- 1998-08-11 PE PE1998000718A patent/PE105799A1/es not_active Application Discontinuation
- 1998-08-21 MY MYPI98003819A patent/MY122272A/en unknown
- 1998-08-23 EG EG98398A patent/EG24075A/xx active
- 1998-08-24 HR HR980461A patent/HRP980461B1/xx not_active IP Right Cessation
- 1998-08-24 ID IDP981156A patent/ID21650A/id unknown
- 1998-08-24 TW TW087113878A patent/TW450812B/zh not_active IP Right Cessation
- 1998-08-24 CO CO98048247A patent/CO4970742A1/es unknown
- 1998-08-24 ZA ZA9807623A patent/ZA987623B/xx unknown
- 1998-08-25 AR ARP980104200A patent/AR016869A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 1998-11-01 SA SA98190680A patent/SA98190680B1/ar unknown
-
2000
- 2000-02-07 BG BG104133A patent/BG64337B1/bg active Active
- 2000-02-24 NO NO20000906A patent/NO326226B1/no not_active IP Right Cessation
- 2000-03-02 US US09/517,564 patent/US6255481B1/en not_active Expired - Lifetime
- 2000-11-20 HK HK00107393A patent/HK1027975A1/xx not_active IP Right Cessation
-
2006
- 2006-08-11 CY CY20061101147T patent/CY1105228T1/el unknown
-
2008
- 2008-10-21 CL CL2008003111A patent/CL2008003111A1/es unknown
-
2011
- 2011-10-14 AR ARP110103815A patent/AR083451A2/es active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR100291A2 (es) | Composición catártica | |
PE20001644A1 (es) | Composicion de un derivado de (5-aril-1,2,4-tiadiazol)-3-il tiourea o un derivado de (5-aril-1,2,4-tiadiazol)-3-il urea para tratar infecciones virales | |
PE20020050A1 (es) | Composicion farmaceutica liquida que contiene eritropoyetina y un anion inorganico | |
EA199800775A1 (ru) | Таблетки, содержащие бетта-лактамный антибиотик, и способ их изготовления | |
BR9913319A (pt) | Composições e métodos para tratamento de doenças mitocondriais | |
BRPI0504445A (pt) | composição de trombina e processo para a sua preparação | |
FR2819723B1 (fr) | Composition halogene, son procede de preparation et ses utilisations | |
AR083451A2 (es) | Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspension farmaceutica | |
CO5560554A2 (es) | Composicion farmaceutica que comprende lumiracoxib | |
AR012321A1 (es) | Procedimiento de enriquecimiento de sal bruta. | |
ES2094702B1 (es) | Composiciones farmaceuticas para la prevencion y el tratamiento de enfermedades cancerosas y procedimiento para su preparacion. | |
KR890006644A (ko) | 결정성 β-락탐 수화물 | |
ES2080726T3 (es) | Compuestos aromaticos o heteroaromaticos nitrosustituidos para su utilizacion en el tratamiento del cancer. | |
KR910700248A (ko) | 위산 분비 억제 효과를 갖는 화합물 및 그의 제조 방법 | |
AR041069A1 (es) | Composicion de tolterodina liquida oral | |
BR0015423A (pt) | Análogos de ácido 15-hidroxieicosatetraenóico interrompidos por heteroátomo e métodos de uso | |
EE04264B1 (et) | Naatriumkloriidi kasutamine aine valmistamiseks kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsete kõrvaltoimete vähendamiseks | |
FR2625679B1 (fr) | Preparation aqueuse a base de sels mineraux et d'acide acetique pour la prevention et le traitement des maladies virales | |
ATE141506T1 (de) | Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff | |
CO5170447A1 (es) | Derivado de benzamida y medicamento que lo contiene | |
MXPA03005676A (es) | Formas de dosis solidas de sodio de divalproex. | |
DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
EA011845B1 (ru) | Способ очистки глины | |
CZ20038A3 (cs) | Vaginální čípky | |
DK0541726T3 (da) | Vækstfaktorsammensætninger, fremstilling og anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |